J vs TENX · P/E 36, rev $4.08B vs P/E 3.4, $24.1M cap
Jacobs Solutions Inc. (J) versus Tenax Therapeutics Inc (TENX) — a side-by-side from cached financials, not a winner call.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Tenax Therapeutics Inc (TENX) is a biotechnology company listed on US.
Latest reported J revenue for 2026-06-26 was $4.08B. Net income was $136.6M. Revenue was down 41.7% from 2026-03-27 to 2026-06-26. J currently screens at market cap $14.40B and trailing P/E 36.0.
Latest reported TENX revenue for 2026-06-30 was $0. Net income was -$33.5M. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
J currently screens at market cap $14.40B and trailing P/E 36.0. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
Not investment advice. Open the J and TENX stock pages for the full models.
Not investment advice.